Key Metrics of Oxford Nanopore Technologies
Competitors10identified
About Oxford Nanopore Technologies
Sectors
Company details
- Website
- nanoporetech.com
Operational Areas of Oxford Nanopore Technologies
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Entity details
CIN—
LEI code—
State code—
PIN code—
Current legal nameOXFORD NANOPORE TECHNOLOGIES
Classification—
Listing status—
Registration no.—
Company age—
PAN—
CountryUnited Kingdom
City—
State—
Current status—
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—
Compliance
Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026
Industry classification
NIC code—
Description of main activity—
Description of business activity—
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Premium
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingFiling compliance
AGM for FY 2025-2630 Sep 2026
Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026
Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026
Statutory due date · 24 days left
Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeOxford Science Park
GSTIN—
Email—
Websitehttp://nanoporetech.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Oxford Nanopore Technologies
Competitors10identified
Locations1most in United Kingdom
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Part of Abcam. | abcam.com/en-us | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | abcodia.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | diabetology.co.uk | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | genusplc.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | selectbiosciences.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | vernalis.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | oxitec.com | — | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | horizondiscovery.com | — | United Kingdom | |
| Part of Immunocore. | immunocore.com | — | United Kingdom |
Similar companies
L
Lineage Cell TherapeuticsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
D
Definium TherapeuticsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
Inovio PharmaceuticalsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
G
Geron CorporationPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
P
Puma BiotechnologyPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
A
AgenusPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
S
Sutro BiopharmaPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
M
MannKind CorporationPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology industry
Filings
No filings on record yet.